EARLY IFNB-1a and Simvastatin Combination Therapy in Clinically Isolated Syndrome Suggestive of Multiple Sclerosis
Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety, tolerability and efficacy of a
combination therapy interferon beta-1a(Avonex) plus simvastatin (Zocor) vs. interferon
beta-1a plus placebo in patients with clinically isolated syndrome suggestive of Multiple
Sclerosis.